Medsmart Group Stock Price, News & Analysis
Company Description
Medsmart Group (OTC Link: MSGP) is a publicly traded medical care facilities company in the Healthcare sector. The company has a market capitalization of $5.2K.
MSGP stock has gained 500.0% over the past year. Shares last traded at $0.0006.
This page provides a comprehensive overview of MSGP stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Medsmart Group (MSGP) stock last traded at $0.0006. Over the past 12 months, the stock has gained 500.0%. At a market capitalization of $5.2K, MSGP is classified as a micro-cap stock with approximately 51.9M shares outstanding.
Latest News
Medsmart Group has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition. View all MSGP news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Medsmart Group (MSGP) currently stands at 2.3 thousand shares. With 232.3 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Medsmart Group (MSGP) currently stands at 232.3 days, down 76.8% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 1.6 to 1000.0 days.
MSGP Company Profile & Sector Positioning
Medsmart Group (MSGP) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing MSGP often look at related companies in the same sector, including Genesis Heal (GENN), ARBORETA HEALTHCARE INC (ARBH), Bionik Labo (BNKL), Clearday Inc (CLRD), and Novo Integrated Sciences Inc (NVOS). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MSGP's relative position within its industry.